Vident Advisory, LLC Neogenomics Inc Transaction History
Vident Advisory, LLC
- $3.62 Trillion
- Q2 2024
A detailed history of Vident Advisory, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Vident Advisory, LLC holds 50,164 shares of NEO stock, worth $699,286. This represents 0.02% of its overall portfolio holdings.
Number of Shares
50,164
Previous 35,608
40.88%
Holding current value
$699,286
Previous $560 Million
24.3%
% of portfolio
0.02%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding NEO
# of Institutions
279Shares Held
127MCall Options Held
581KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$274 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$197 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$122 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$93.8 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$92.3 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.75B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...